{"name":"AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan","series":"","short":"","website":"https://go.evvnt.com/355503-0?pid=4868","content":"Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo. AsiaTIDES 2019 keynote presentation lineup: 1) The Discovery of Semaglutide â€“ A Journey from Ala Scan to Structural Design of GLP-1 Analogues - Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S 2) New Strategies and Technologies in Oligonucleotide Therapeutic Development - Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals 3) The Chemistry behind Approved Oligonucleotide Therapeutics - Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc. 4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics - Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences URLs: Tickets https://go.evvnt.com/355503-2?pid=4868 Brochure https://go.evvnt.com/355503-3?pid=4868 Prices: Conference Pass + Pre-Conference Workshop: USD 3023.0 Conference Pass: USD 2375.0 Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences Time: 9:00 am - 5:00 pm","date_start":"2019-02-26","date_end":"2019-02-28","important_dates":{"abstract":"","full":"2019-02-25","notification":"","final":""},"topics":["Education / Legal / Other","Education","Education, teaching"],"location":{"virtual":"","full":["Urayasu","shi","Japan"],"name":"","street":"","city":"Urayasu","state":"shi","ZIP":"","country":"Japan"},"organizers":["KNect365 Life Sciences"],"societies":[],"indexes":[],"emails":[]}